GlassScriptPhysician profile
Craig Anthony Schuring
NPI 1447698360
$12,425.65
in general payments reported to CMS, 2019-2025
42 companies · $2,374 in 2025
The $2,374 reported for 2025 was more than what 88% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,228 · 2020: $366 · 2021: $1,533 · 2022: $1,971 · 2023: $2,086 · 2024: $1,867 · 2025: $2,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,182 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,181.61 |
| Education | $145.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $2,149.79 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,853.58 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,142.82 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $918.60 | 2020-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $651.21 | 2020-2025 | Ofev, Stiolto Respimat |
| Mallinckrodt Hospital Products INC. | $598.71 | 2021-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $578.82 | 2019-2025 | Dupixent |
| Genzyme Corporation | $549.20 | 2021-2025 | |
| Insmed, INC. | $525.07 | 2019-2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $378.86 | 2021-2025 | Winrevair, Zerbaxa, Keytruda |
| United Therapeutics Corporation | $373.44 | 2021-2025 | Tyvaso, Tyvaso |
| Jazz Pharmaceuticals INC. | $282.60 | 2019-2025 | |
| Amgen INC. | $249.11 | 2022-2025 | Tezspire |
| Electromed, INC. | $224.60 | 2021-2025 | Smartvest |
| Mylan Specialty L.P. | $216.53 | 2020-2024 | Yupelri |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $205.32 | 2022-2025 | Sunosi |
| Baxter Healthcare | $181.20 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $166.82 | 2023-2025 | Glassia, Hyqvia |
| Philips North America LLC | $125.15 | 2021-2025 | Vest Therapy Und |
| Harmony Biosciences LLC | $119.88 | 2021-2023 | Wakix |
| Verona Pharma, INC. | $117.22 | 2025 | Ohtuvayre |
| Avadel Cns Pharmaceuticals, LLC | $105.51 | 2025 | Lumryz |
| Advanced Respiratory, INC | $89.15 | 2021 | |
| Viatris Specialty LLC | $76.76 | 2025 | Yupelri |
| Inogen, INC. | $74.50 | 2021-2024 | Inogen |
| Abbvie INC. | $70.17 | 2021-2024 | |
| Optinose US, INC. | $47.02 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $46.02 | 2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $39.43 | 2022-2023 | Xolair |
| Novartis Pharmaceuticals Corporation | $33.60 | 2023-2025 | |
| Ethicon INC. | $31.21 | 2025 | Monarch Platform |
| Alexion Pharmaceuticals, INC. | $28.86 | 2021 | |
| Resmed Corp | $23.73 | 2021 | |
| Grifols USA, LLC | $23.07 | 2025 | Xembify |
| Intuitive Surgical, INC. | $20.44 | 2021 | |
| Liquidia Technologies, INC. | $20.27 | 2025 | Yutrepia |
| Apria Healthcare LLC | $20.12 | 2021 | |
| Astellas Pharma US INC | $20.07 | 2025 | Cresemba |
| Teva Pharmaceuticals USA, INC. | $14.31 | 2022 | |
| Fisher & Paykel Healthcare INC | $11.89 | 2020 | |
| Ambu INC. | $11.40 | 2021 | |
| Biomerieux INC | $9.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Schuring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.